Cargando…
Molecular monitoring of Plasmodium falciparum resistance to artemisinin in Tanzania
Artemisinin-based combination therapies (ACTs) are recommended for use against uncomplicated malaria in areas of multi-drug resistant malaria, such as sub-Saharan Africa. However, their long-term usefulness in these high transmission areas remains unclear. It has been suggested that documentation of...
Autores principales: | Mugittu, Kefas, Genton, Blaise, Mshinda, Hassan, Beck, Hans Peter |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1764422/ https://www.ncbi.nlm.nih.gov/pubmed/17177997 http://dx.doi.org/10.1186/1475-2875-5-126 |
Ejemplares similares
-
Efficacy of sulfadoxine-pyrimethamine in Tanzania after two years as first-line drug for uncomplicated malaria: assessment protocol and implication for treatment policy strategies
por: Mugittu, Kefas, et al.
Publicado: (2005) -
Efficacy and safety of artemisinin-based antimalarial in the treatment of uncomplicated malaria in children in southern Tanzania
por: Kabanywanyi, Abdunoor M, et al.
Publicado: (2007) -
Exploration of in vivo efficacy of artemether-lumefantrine against uncomplicated Plasmodium falciparum malaria in under fives in Tabora region, Tanzania
por: Joseph, Deokary, et al.
Publicado: (2013) -
Plasmodium falciparum msp1, msp2 and glurp allele frequency and diversity in sub-Saharan Africa
por: Mwingira, Felista, et al.
Publicado: (2011) -
Drug resistance to sulphadoxine-pyrimethamine in Plasmodium falciparum malaria in Mlimba, Tanzania
por: Mbugi, Erasto V, et al.
Publicado: (2006)